News Announcement

Indo US Bio-Tech: Revised-Financial Results For March 31 2022

This is to inform that there was an inadvertent typo error in the submitted Standalone Financial Results dated 30.05.2022.
Suo-motto we are submitting the Revised Pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.
We hereby enclose the following documents again.
1. Revised Statement of Standalone Audited Financial Results of the Company for quarter and year ended on 31st March 2022.
2. Consolidated Audited Financial Results of the Company for quarter and year ended on 31st March 2022.
3. Auditors Report on Standalone and Consolidated Audited Financial Results.
These Revised File is also being made available on the website of the Company at www.indousagriseeds.com.
Please take the same on your records.

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.


Mutual Fund Insight turns 24! 🎉 Get 2 FREE anniversary guides: The Right SIP + The Big Funds